Taysha Gene Therapies Inc. (TSHA) Social Stream



Taysha Gene Therapies Inc. (TSHA): $3.82

0.30 (+8.52%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TSHA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Taysha Gene Therapies Inc (TSHA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Taysha Gene Therapies Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 11 $60 $34 $45.6 $6.52 599.39%
2021-11-11 11 $60 $33 $44.9 $6.52 588.65%
2022-01-27 12 $60 $28 $43.363 $6.52 565.08%
2022-01-31 12 $60 $28 $42.545 $6.52 552.53%
2022-03-01 13 $60 $25 $41.083 $6.52 530.11%
2022-03-09 14 $60 $25 $39.923 $6.52 512.32%

The Trend in the Analyst Price Target


TSHA's average price target has moved down $4.02 over the prior 38 weeks.

Over the past 49 weeks, TSHA's average upside potential has been 182.9%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 3 60.0 30 40.40 20.20 100%
2021-05-15 3 67.5 36 47.30 20.94 125.88%
2021-08-07 11 67.5 33 45.68 17.97 154.2%
2021-08-14 11 67.5 33 45.68 17.38 162.83%
2021-08-28 11 60.0 34 44.27 19.70 124.72%

TSHA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.11 12 2 0 0 0 14

The Trend in the Broker Recommendations


TSHA's average broker recommendation rating improved by 0.03 over the prior 90 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TSHA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Taysha Gene Therapies Inc's upside potential (average analyst target price relative to current price) is higher than 581.12% of them.
  • In terms of how Taysha Gene Therapies Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 597.72% of that group.
  • TSHA has a greater average analyst price target than 499.02% of stocks in the small market cap category.
  • In terms of how Taysha Gene Therapies Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -383.88% of that group.

Stocks similar to Taysha Gene Therapies Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TNYA, TARS, and TALS.

Make investment decisions regarding TSHA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4283 seconds.